KRAS and familial pancreatic carcinoma: Experimental manipulation of the LIN28-let-7-KRas regulatory network by let-7 overexpression and LIN28 silencing caused radio-sensitization of KRas mutant lung and pancreatic cancer cells129, suggesting that let-7 and KRas might serve as markers of survival and therapeutic response.